Trial Profile
Drug Use Investigation For HIV Infection Patients Of Mycobutin (Regulatory Post Marketing Commitment Plan)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Rifabutin (Primary)
- Indications Mycobacterium avium complex infections
- Focus Adverse reactions
- Sponsors Pfizer
- 29 Jun 2018 Status changed from active, no longer recruiting to completed.
- 16 Aug 2017 Planned End Date changed from 1 May 2018 to 17 Jul 2018.
- 16 Aug 2017 Planned primary completion date changed from 1 May 2018 to 17 Jul 2018.